Article info
PostScript
Letter
Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
- Correspondence to Dr Gilaad G Kaplan, Medicine and Community Health Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada; ggkaplan{at}ucalgary.ca
Citation
Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
Publication history
- Received March 24, 2022
- Accepted May 13, 2022
- First published May 23, 2022.
Online issue publication
March 07, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.